News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Active Biotech AB (BTPC) Interim Report January - June 2013


8/7/2013 9:47:15 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Events during January - June 2013: Laquinimod
· positive results from Phase IIa study of laquinimod in active lupus nephritis
· Teva plans continued clinical development of laquinimod for the treatment of lupus nephritis

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES